Please assess the completion status of the following clinical trial:

Trial Title: Ad Hoc Percutaneous Coronary Intervention Study in Acute Coronary Syndrome Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Provision of signed and dated informed consent before initiation of any study-related procedures~* Male or female patients aged 18 years or older~* Documented acute coronary syndrome and troponin negative and undergoing Ad Hoc percutaneous coronary intervention (PCI)~* Females must be post menopausal or surgically sterile~* Taking aspirin as an anti-platelet medication~Exclusion Criteria:~* Use of any thienopyridine or ticagrelor within 7 days prior to randomization~* Any indication for oral anticoagulant (e.g., atrial fibrillation, mitral stenosis or prosthetic heart valve)~* Contraindication that ticagrelor or clopidogrel should not be administered Patient requires dialysis~* History of intolerance or allergy to aspirin

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 130 Years
- Healthy Volunteers: f

Study Arms:
- Ticagrelor (Type: EXPERIMENTAL): Ticagrelor - 180 mg loading dose
- Clopidogrel (Type: ACTIVE_COMPARATOR): Clopidogrel - 600 mg loading dose

Based on this trial design, predict the completion outcome and termination type (if applicable).